Nasdaq · CIK 0000899460
MNKD MANNKIND CORP
Insider trading from SEC Form 4. Last filing 14 d ago. Close $3.29 on Oct 9, 2026, +44% from the 52-week low and -47% from the high.
Last 90 days
Net insider value
-$256k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$256k by 1 insider
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
MNKDOct 9, 2026 · close 3.29
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MANNKIND CORP, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | Steven B. Binder director sell | $128k 39,051 shares | -5% | - | |
| 6Weak | Steven B. Binder director sell | $128k 33,558 shares | -4% | - | |
| 9Weak | Steven B. Binder director sell | $297k 75,367 shares | -8% | +12% from low-47% from high | |
| 8Weak | Steven B. Binder director sell | $256k 64,085 shares | -6% | 0% from low-47% from high | |
| 10Weak | Steven B. Binder director sell | $53k 12,078 shares | -1% | 0% from low-41% from high | |
| 3Weak | David Thomson EVP Genl Counsel & Secretary sell | $10k 2,345 shares | -0% | 0% from low-41% from high | |
| 19Weak | Steven B. Binder director sell | $376k 80,144 shares | -7% | +6% from low-37% from high | |
| 14Weak | David Thomson EVP Genl Counsel & Secretary sell | $151k 32,179 shares | -4% | +6% from low-37% from high | |
| 0Weak | Steven B. Binder director sell | $465k 67,536 shares | -6% | - | |
| 5Weak | Steven B. Binder director sell | $457k 67,539 shares | -6% | - | |
| 19Weak | Stuart A Tross Chief People & Workpl Officer sell | $404k 55,000 shares | -5% | - |
Transactions
The last 69 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -39,051 | $3.29 | $128k | 713,258 | 14 d ago |
| Sep 10, 2026 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -33,558 | $3.81 | $128k | 752,309 | 28 d ago |
| Jul 15, 2025 | Burkhard Blank EVP Chief Medical Officer | FTax withholding Common Stock, $0.01 Par Value | -9,556 | $3.85 | $37k | 460,791 | Jul 17, 2025 |
| Jul 15, 2025 | Steven B. Binder director | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -19,383 | $3.85 | $75k | 905,875 | Jul 17, 2025 |
| Jul 15, 2025 | Michael Castagna Chief Executive Officer | FTax withholding Common Stock, $0.01 Par Value | -111,275 | $3.85 | $428k | 2,504,792 | Jul 17, 2025 |
| Jul 16, 2025 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -75,367 | $3.94 | $297k | 830,508 | Jul 17, 2025 |
| Jun 23, 2025 | Dominic Marasco Pres, Endocrine Business Unit | AGrant or award Performance Restricted Stock Unitderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Jun 25, 2025 |
| Jun 10, 2025 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -64,085 | $4.00 | $256k | 925,258 | Jun 10, 2025 |
| May 27, 2025 | Burkhard Blank EVP Chief Medical Officer | FTax withholding Common Stock, $0.01 Par Value | -15,630 | $4.12 | $64k | 465,124 | May 27, 2025 |
| May 19, 2025 | Stuart A Tross Chief People & Workpl Officer | FTax withholding Common Stock, $0.01 Par Value | -6,147 | $4.37 | $27k | 1,090,427 | May 20, 2025 |
| May 19, 2025 | Steven B. Binder director | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -5,190 | $4.37 | $23k | 1,001,421 | May 20, 2025 |
| May 19, 2025 | Michael Castagna Chief Executive Officer | FTax withholding Common Stock, $0.01 Par Value | -26,114 | $4.37 | $114k | 2,612,934 | May 20, 2025 |
| May 19, 2025 | David Thomson EVP Genl Counsel & Secretary | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -9,536 | $4.37 | $42k | 881,891 | May 20, 2025 |
| May 20, 2025 | David Thomson EVP Genl Counsel & Secretary | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -2,345 | $4.41 | $10k | 879,546 | May 20, 2025 |
| May 20, 2025 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -12,078 | $4.40 | $53k | 989,343 | May 20, 2025 |
| May 14, 2025 | Anthony C Hooper director | AGrant or award Common Stock, $0.01 Par Value | +25,000 | $4.56 | $114k | 201,153 | May 16, 2025 |
| May 14, 2025 | Dominic Marasco Pres, Endocrine Business Unit | AGrant or award Common Stock, $0.01 Par Value | +59,500 | $0.00 | $0 | 311,500 | May 16, 2025 |
| May 14, 2025 | James Samuel Shannon director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Christine Mundkur director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Sabrina Kay director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Jennifer Grancio director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Michael A Friedman director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Michael Castagna Chief Executive Officer | AGrant or award Common Stock, $0.01 Par Value | +27,000 | $4.56 | $123k | 2,639,048 | May 16, 2025 |
| May 14, 2025 | Ronald J Consiglio director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Anthony C Hooper director | AGrant or award Restricted Stock Unitderivative | +52,854 | $0.00 | $0 | 52,854 | May 16, 2025 |
| May 14, 2025 | Sabrina Kay director | AGrant or award Restricted Stock Unitderivative | +10,571 | $0.00 | $0 | 10,571 | May 16, 2025 |
| May 14, 2025 | Dominic Marasco Pres, Endocrine Business Unit | AGrant or award Common Stock, $0.01 Par Value | +21,929 | $4.56 | $100k | 333,429 | May 16, 2025 |
| May 14, 2025 | Anthony C Hooper director | AGrant or award Restricted Stock Unitderivative | +10,571 | $0.00 | $0 | 10,571 | May 16, 2025 |
| May 14, 2025 | Dominic Marasco Pres, Endocrine Business Unit | AGrant or award Performance Restricted Stock Unitderivative | +72,500 | $0.00 | $0 | 72,500 | May 16, 2025 |
| May 10, 2025 | Stuart A Tross Chief People & Workpl Officer | AGrant or award Common Stock, $0.01 Par Value | +105,600 | $0.00 | $0 | 1,072,791 | May 15, 2025 |
| May 13, 2025 | Sanjay R Singh EVP Technical Operations | AGrant or award Common Stock, $0.01 Par Value10b5-1 | +119,000 | $0.00 | $0 | 506,509 | May 15, 2025 |
| May 10, 2025 | David Thomson EVP Genl Counsel & Secretary | AGrant or award Common Stock, $0.01 Par Value10b5-1 | +105,600 | $0.00 | $0 | 935,443 | May 15, 2025 |
| May 13, 2025 | Christopher B Prentiss Chief Financial Officer | AGrant or award Common Stock, $0.01 Par Value10b5-1 | +119,000 | $0.00 | $0 | 353,193 | May 15, 2025 |
| May 10, 2025 | Steven B. Binder director | AGrant or award Common Stock, $0.01 Par Value10b5-1 | +105,600 | $0.00 | $0 | 1,180,626 | May 15, 2025 |
| May 10, 2025 | Michael Castagna Chief Executive Officer | AGrant or award Common Stock, $0.01 Par Value | +298,560 | $0.00 | $0 | 2,553,896 | May 15, 2025 |
| May 13, 2025 | Christopher B Prentiss Chief Financial Officer | AGrant or award Performance Restricted Stock Unitderivative10b5-1 | +145,000 | $0.00 | $0 | 145,000 | May 15, 2025 |
| May 12, 2025 | David Thomson EVP Genl Counsel & Secretary | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -118,473 | $4.56 | $540k | 816,970 | May 15, 2025 |
| May 12, 2025 | Stuart A Tross Chief People & Workpl Officer | FTax withholding Common Stock, $0.01 Par Value | -88,724 | $4.56 | $405k | 984,067 | May 15, 2025 |
| May 12, 2025 | Michael Castagna Chief Executive Officer | FTax withholding Common Stock, $0.01 Par Value | -334,954 | $4.56 | $1.5M | 2,218,942 | May 15, 2025 |
| May 12, 2025 | Steven B. Binder director | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -87,430 | $4.56 | $399k | 1,093,196 | May 15, 2025 |
| May 13, 2025 | Sanjay R Singh EVP Technical Operations | AGrant or award Performance Restricted Stock Unitderivative10b5-1 | +145,000 | $0.00 | $0 | 145,000 | May 15, 2025 |
| May 12, 2025 | Steven B. Binder director | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -6,441 | $4.56 | $29k | 1,086,755 | May 15, 2025 |
| May 12, 2025 | Michael Castagna Chief Executive Officer | FTax withholding Common Stock, $0.01 Par Value | -34,894 | $4.56 | $159k | 2,184,048 | May 15, 2025 |
| May 12, 2025 | Stuart A Tross Chief People & Workpl Officer | FTax withholding Common Stock, $0.01 Par Value | -8,051 | $4.56 | $37k | 976,016 | May 15, 2025 |
| May 12, 2025 | David Thomson EVP Genl Counsel & Secretary | FTax withholding Common Stock, $0.01 Par Value10b5-1 | -12,364 | $4.56 | $56k | 804,606 | May 15, 2025 |
| May 13, 2025 | David Thomson EVP Genl Counsel & Secretary | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -32,179 | $4.68 | $151k | 772,427 | May 15, 2025 |
| May 13, 2025 | Stuart A Tross Chief People & Workpl Officer | AGrant or award Common Stock, $0.01 Par Value | +119,000 | $0.00 | $0 | 1,096,574 | May 15, 2025 |
| May 13, 2025 | Michael Castagna Chief Executive Officer | AGrant or award Common Stock, $0.01 Par Value | +428,000 | $0.00 | $0 | 2,612,048 | May 15, 2025 |
| May 13, 2025 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -80,144 | $4.69 | $376k | 1,006,611 | May 15, 2025 |
| May 13, 2025 | Stuart A Tross Chief People & Workpl Officer | AGrant or award Performance Restricted Stock Unitderivative | +145,000 | $0.00 | $0 | 145,000 | May 15, 2025 |
| May 13, 2025 | Michael Castagna Chief Executive Officer | AGrant or award Performance Restricted Stock Unitderivative | +523,000 | $0.00 | $0 | 523,000 | May 15, 2025 |
| May 14, 2025 | Steven B. Binder director | AGrant or award Restricted Stock Unitderivative10b5-1 | +52,854 | $0.00 | $0 | 52,854 | May 15, 2025 |
| May 13, 2025 | David Thomson EVP Genl Counsel & Secretary | AGrant or award Common Stock, $0.01 Par Value10b5-1 | +119,000 | $0.00 | $0 | 891,427 | May 15, 2025 |
| May 13, 2025 | David Thomson EVP Genl Counsel & Secretary | AGrant or award Performance Restricted Stock Unitderivative10b5-1 | +145,000 | $0.00 | $0 | 145,000 | May 15, 2025 |
| Apr 4, 2025 | Michael Castagna Chief Executive Officer | JOther Common Stock, $0.01 Par Value | -39,500 | $0.00 | $0 | 2,255,336 | Apr 4, 2025 |
| Nov 22, 2024 | Steven B. Binder director | MOption exercise Common Stock, $0.01 Par Value10b5-1 | +67,536 | $1.47 | $99k | 1,142,562 | Nov 25, 2024 |
| Nov 22, 2024 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -67,536 | $6.89 | $465k | 1,075,026 | Nov 25, 2024 |
| Nov 22, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,512 | $0.00 | $0 | 0 | Nov 25, 2024 |
| Nov 22, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,512 | $0.00 | $0 | 0 | Nov 25, 2024 |
| Nov 22, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,512 | $0.00 | $0 | 0 | Nov 25, 2024 |
| Nov 15, 2024 | Steven B. Binder director | MOption exercise Common Stock, $0.01 Par Value10b5-1 | +67,539 | $1.47 | $99k | 1,142,565 | Nov 19, 2024 |
| Nov 15, 2024 | Steven B. Binder director | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -67,539 | $6.76 | $457k | 1,075,026 | Nov 19, 2024 |
| Aug 7, 2023 | Steven B. Binder director | AGrant or award Employee Stock Option (Right to Buy)derivative10b5-1 | +45,025 | $0.00 | $0 | 45,025 | Nov 19, 2024 |
| Nov 15, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,513 | $0.00 | $0 | 22,512 | Nov 19, 2024 |
| Nov 15, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,513 | $0.00 | $0 | 22,512 | Nov 19, 2024 |
| Nov 15, 2024 | Steven B. Binder director | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -22,513 | $0.00 | $0 | 22,512 | Nov 19, 2024 |
| Nov 18, 2024 | Steven B. Binder director | AGrant or award Deferred Restricted Stock Unitderivative10b5-1 | +17,575 | $0.00 | $0 | 17,575 | Nov 19, 2024 |
| Nov 6, 2024 | Stuart A Tross Chief People & Workpl Officer | SOpen-market sale Common Stock, $0.01 Par Value10b5-1 | -55,000 | $7.34 | $404k | 967,191 | Nov 8, 2024 |
| Oct 31, 2024 | Sanjay R Singh EVP Technical Operations | FTax withholding Common Stock, $0.01 Par Value | -17,071 | $7.07 | $121k | 385,416 | Nov 4, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Burkhard BlankEVP Chief Medical Officer
- Steven B. Binderdirector
- Ronald J Consigliodirector
- Michael CastagnaChief Executive Officer
- Michael A Friedmandirector
- Jennifer Granciodirector
- Anthony C Hooperdirector
- Sabrina Kaydirector
- Christine Mundkurdirector
- Dominic MarascoPres, Endocrine Business Unit
- Christopher B PrentissChief Financial Officer
- James Samuel Shannondirector
- Sanjay R SinghEVP Technical Operations
- David ThomsonEVP Genl Counsel & Secretary
- Stuart A TrossChief People & Workpl Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.